Zaslal: pá 26. duben, 2024 9:27 Předmět: Monoclonal Antibodies Market Analysis and Key Players' Role
The global monoclonal antibodies market size was USD 204.42 billion in 2022 and is expected to register a revenue CAGR of 10.8% during the forecast period. Rising adoption in personalized medicine and precision therapies, expanding regulatory approvals of monoclonal antibodies by regulatory agencies across the globe, and increasing technological advancements in biotechnology and immunology are some of the factors expected to drive market revenue growth.
The research report on the Monoclonal Antibodies market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Monoclonal Antibodies business sphere.
The leading market contenders listed in the report are:
Novartis AG; Pfizer Inc; GlaxoSmithKline plc; Amgen Inc.; Merck & Co., Inc.; Daiichi Sankyo Company, Limited; Abbott Laboratories; AstraZeneca plc; Eli Lilly And Company; Johnson & Johnson Services, Inc.; Bayer AG; Bristol Myers Squibb; F. Hoffman-La Roche Ltd.; Viatris Inc.; Biogen Inc.; Thermo Fisher Scientific, Inc.; Novo Nordisk A/S; Sanofi S.A., and Teva Pharmaceutical Industries Ltd
The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs.
The report bifurcates the Monoclonal Antibodies market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Source Outlook (Revenue, USD Billion; 2019-2032)
Humanized mAb
Human mAb
Murine mAb
Chimeric mAb
Indication Outlook (Revenue, USD Billion; 2019-2032)
Cancer
Breast cancer
Colorectal cancer
Lung cancer
Ovarian cancer
Others
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Others
Production Type Outlook (Revenue, USD Billion; 2019-2032)
In Vivo
In Vitro
The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key reasons to buy the Global Monoclonal Antibodies Market report:
The latest report comprehensively studies the global Monoclonal Antibodies market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
The report offers an insightful analysis of the regional outlook of the market.
It offers a detailed account of the end-use applications of the products & services offered by this industry.
The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2533
Nemůžete odesílat nové téma do tohoto fóra. Nemůžete odpovídat na témata v tomto fóru. Nemůžete upravovat své příspěvky v tomto fóru. Nemůžete mazat své příspěvky v tomto fóru. Nemůžete hlasovat v tomto fóru.